{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:08:25Z","timestamp":1758816505099},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11926-008-0013-x","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T20:21:56Z","timestamp":1209932516000},"page":"74-80","source":"Crossref","is-referenced-by-count":5,"title":["The enigmas of the lupus anticoagulant: Mechanisms, diagnosis, and management"],"prefix":"10.1007","volume":"10","author":[{"given":"Richard A.","family":"Marlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,4]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(08)60777-4","volume":"49","author":"H.P. McNeil","year":"1991","unstructured":"McNeil HP, Chesterman CN, Krilis S: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991, 49:193\u2013280.","journal-title":"Adv Immunol"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S. Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006, 4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000083810","volume":"33","author":"M. Galli","year":"2003","unstructured":"Galli M: Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemostas Thromb 2003, 33:249\u2013258.","journal-title":"Pathophysiol Haemostas Thromb"},{"key":"13_CR4","first-page":"75","volume":"1","author":"D.I. Feinstein","year":"1972","unstructured":"Feinstein DI, Rapaport SI: Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972, 1:75\u201395","journal-title":"Prog Hemost Thromb"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","volume":"74","author":"J.T. Brandt","year":"1995","unstructured":"Brandt JT, Triplett DA, Alving B, Scharrer I: Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemostas 1995, 74:1185\u20131190.","journal-title":"Thromb Haemostas"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood-2004-03-1107","volume":"104","author":"H.B. Laat de","year":"2004","unstructured":"de Laat HB, Derksen RH, Urbanus RT, et al.: Beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004, 104:3598\u20133602.","journal-title":"Blood"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.thromres.2007.01.001","volume":"120","author":"T. Sailer","year":"2007","unstructured":"Sailer T, Vormittag R, Zoghlami C, et al.: The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant. Thromb Res 2007, 120:295\u2013302.","journal-title":"Thromb Res"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2006-04-001206","volume":"109","author":"B. Gainnakopoulos","year":"2007","unstructured":"Gainnakopoulos B, Passam F, Rahgozar S, Krillis SA: Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007, 109:422\u2013430.","journal-title":"Blood"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1538-7836.2005.01485.x","volume":"3","author":"P.G. Groot de","year":"2005","unstructured":"de Groot PG, Derksen RH: Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 2005, 3:1854\u20131860.","journal-title":"J Thromb Haemost"},{"issue":"Suppl1","key":"13_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","volume":"5","author":"J.H. Griffin","year":"2007","unstructured":"Griffin JH, Fernadndez JA, Gale AJ, Mosinier LO: Activated protein C. J Thromb Haemostas 2007, 5(Suppl 1):73\u201380.","journal-title":"J Thromb Haemostas"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.ATV.0000132408.13064.09","volume":"24","author":"A. Buil","year":"2004","unstructured":"Buil A, Soria JM, Souto JC, et al.: Protein C levels are regulated by a quantitative trait locus on chromosome 16: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biool 2004, 24:1321\u20131325.","journal-title":"Arterioscler Thromb Vasc Biool"},{"key":"13_CR12","first-page":"384","volume":"27","author":"C.W. Carson","year":"2000","unstructured":"Carson CW, Comp PC, Rezaie AR, et al.: Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol 2000, 27:384\u2013390.","journal-title":"J Rheumatol"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1182\/blood-2005-01-0404","volume":"106","author":"O. Safa","year":"2005","unstructured":"Safa O, Esmon CT, Esmon NL: Inhibition of APC anticoagulant activity on oxidized phospholipid by antibeta2-glycoprotein I monoclonal antibodies. Blood 2005, 106:1629\u20131635.","journal-title":"Blood"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1538-7836.2003.00303.x","volume":"1","author":"R.R. Forastiero","year":"2003","unstructured":"Forastiero RR, Martinuzzo ME, Lu L, Broze GJ: Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z\/protein Z-dependent protease inhibitor. J Thromb Haemost 2003, 1:1764\u20131770.","journal-title":"J Thromb Haemost"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0037-1614082","volume":"84","author":"I. Salemink","year":"2000","unstructured":"Salemink I, Blezer R, Willems GM, et al.: Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor. Thromb Haemost 2000, 84:653\u2013656.","journal-title":"Thromb Haemost"},{"issue":"Suppl2","key":"13_CR16","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1177\/096120339800700211","volume":"7","author":"P.L. Meroni","year":"1998","unstructured":"Meroni PL, Del Papa N, Raschi E, et al.: Beta2-glycoprotein I as a \u2018cofactor\u2019 for anti-phospholipid reactivity with endothelial cells. Lupus 1998, 7(Suppl 2):S44\u2013S47.","journal-title":"Lupus"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"33831","DOI":"10.1074\/jbc.M212655200","volume":"278","author":"B.C. Lutters","year":"2003","unstructured":"Lutters BC, Derksen RH, Tekelenburg WL, et al.: Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2\u2032. J Biol Chem 2003, 278:33831\u201333838.","journal-title":"J Biol Chem"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2006.05994.x","volume":"133","author":"A.M. Patterson","year":"2006","unstructured":"Patterson AM, Ford I, Graham A, et al.: The influence of anti-endothelial\/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. Br J Haematol 2006, 133:323\u2013330.","journal-title":"Br J Haematol"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI4985","volume":"104","author":"V. Combes","year":"1999","unstructured":"Combes V, Simon AC, Grau GE, et al.: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104:93\u2013102.","journal-title":"J Clin Invest"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00404-003-0547-0","volume":"270","author":"E. Arslan","year":"2004","unstructured":"Arslan E, Colakolu M, Celik C, et al.: Serum TNF-alpha, IL-6, lupus anticoagulant and anticardiolipin antibody in women with and without a past history of recurrent miscarriage. Archiv Gynocol Obst 2004, 270:227\u2013229.","journal-title":"Archiv Gynocol Obst"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1160\/TH03-07-0487","volume":"91","author":"F. Dignat-George","year":"2004","unstructured":"Dignat-George F, Camoin-Jau L, Sabatier F, et al.: Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 2004, 91:667\u2013673.","journal-title":"Thromb Haemost"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1055\/s-0037-1614881","volume":"82","author":"P.M. Dobado-Berrios","year":"1999","unstructured":"Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Aguirre MA: Torres A. Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemostas 1999, 82:1578\u20131582.","journal-title":"Thromb Haemostas"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2004-01-0145","volume":"104","author":"H. Zhou","year":"2004","unstructured":"Zhou H, Wolberg AS, Roubey RA: Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004, 104:2353\u20132358.","journal-title":"Blood"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","volume":"44","author":"P.L. Meroni","year":"2001","unstructured":"Meroni PL, Raschi E, Testoni C, et al.: Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001, 44:2870\u20132878.","journal-title":"Arthritis Rheum"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","volume":"101","author":"E. Raschi","year":"2003","unstructured":"Raschi E, Testoni C, Bosisio D, et al.: Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003, 101:3495\u20133500.","journal-title":"Blood"},{"key":"13_CR26","first-page":"51","volume":"25","author":"D.L. Robbins","year":"1998","unstructured":"Robbins DL, Leung S, Miller-Blair DJ, Ziboh V: Effect of anticardiolipin\/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome. J Rheumatol 1998, 25:51\u201356.","journal-title":"J Rheumatol"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood.V99.1.151","volume":"99","author":"C.L. Yap","year":"2002","unstructured":"Yap CL, Anderson KE, Hughan SC, et al.: Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib\/V\/IX and integrin alpha(IIb)beta(3). Blood 2002, 99:151\u2013158.","journal-title":"Blood"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","volume":"107","author":"G. Cesarman-Maus","year":"2006","unstructured":"Cesarman-Maus G, Rios-Luna NP, Deora AB, et al.: Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 2006, 107:4375\u20134382.","journal-title":"Blood"},{"key":"13_CR29","first-page":"726","volume":"1","author":"D.A. Triplett","year":"2003","unstructured":"Triplett DA: Antiphospholipid antibodies. Clin Adv in Hematol Oncol 2003, 1:726\u2013730.","journal-title":"Clin Adv in Hematol Oncol"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1055\/s-0037-1613896","volume":"83","author":"E.M. Jacobsen","year":"2000","unstructured":"Jacobsen EM, Barna-Cler L, Taylor JM, et al.: The Lupus Ratio test-an interlaboratory study on the detection of lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants-ISLA 5. Thromb Haemost 2000, 83:704\u2013708.","journal-title":"Thromb Haemost"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2005-863804","volume":"31","author":"R.C. Wong","year":"2005","unstructured":"Wong RC, Adelstein S, Gillis D, Favaloro EJ: Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost 2005, 31:39\u201348.","journal-title":"Semin Thromb Hemost"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M. Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003, 101:1827\u20131832.","journal-title":"Blood"},{"key":"13_CR33","first-page":"985","volume":"30","author":"G. Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, et al.: Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003, 30:985\u2013992.","journal-title":"J Rheumatol"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.thromres.2004.08.005","volume":"114","author":"D.W. Branch","year":"2004","unstructured":"Branch DW: Antiphospholipid antibodies and fetal compromise. Thromb Res 2004, 114:415\u2013418.","journal-title":"Thromb Res"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","volume":"25","author":"J.T. Horn Van","year":"2004","unstructured":"Van Horn JT, Craven C, Ward K, et al.: Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004, 25:642\u2013648.","journal-title":"Placenta"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","volume":"17","author":"N.J. Sebire","year":"2002","unstructured":"Sebire NJ, Fox H, Backos M, et al.: Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002, 17:1067\u20131071.","journal-title":"Hum Reprod"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0037-1614567","volume":"81","author":"A.S. Lawrie","year":"1999","unstructured":"Lawrie AS, Mackie IJ, Purdy G, Machin SJ: The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thromb Haemost 1999, 81:758\u2013762.","journal-title":"Thromb Haemost"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00001721-199704000-00001","volume":"8","author":"V. Brancaccio","year":"1997","unstructured":"Brancaccio V, Ames PR, Glynn J, et al.: A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent. Blood Coagul Fibrinolysis 1997, 8:155\u2013160.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(01)00365-6","volume":"104","author":"E.M. Jacobsen","year":"2001","unstructured":"Jacobsen EM, Barna-Cler L, Taylor JM, et al.: The evaluation of clotting times in the laboratory detection of lupus anticoagulants. Thromb Res 2001, 104:275\u2013282.","journal-title":"Thromb Res"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1613238","volume":"88","author":"A. Tripodi","year":"2002","unstructured":"Tripodi A, Chantarangkul V, Clerici M, Mannucci PM: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost 2002, 88:583\u2013586.","journal-title":"Thromb Haemost"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0037-1616204","volume":"86","author":"J. Arnout","year":"2001","unstructured":"Arnout J: Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 2001, 86:83\u201391.","journal-title":"Thromb Haemost"},{"key":"13_CR42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0037-1616090","volume":"86","author":"A. Querrec Le","year":"2001","unstructured":"Le Querrec A, Arnout J, Arnoux D, et al.: Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies. Thromb Haemost 2001, 86:584\u2013589.","journal-title":"Thromb Haemost"},{"key":"13_CR43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.20750","volume":"82","author":"S. Clauser","year":"2007","unstructured":"Clauser S, Fischer AM, Darnige L: Quinidine-induced lupus anticoagulant, hypoprothrombinemia, and antiprothrombin antibodies. Am J Hematol 2007, 82:330.","journal-title":"Am J Hematol"},{"key":"13_CR44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","volume":"109","author":"M. Greaves","year":"2000","unstructured":"Greaves M, Cohen H, Machin SJ, Mackie I: Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000, 109:704\u2013715.","journal-title":"Br J Haematol"},{"key":"13_CR45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/107602960200800410","volume":"8","author":"S.R. Deitcher","year":"2002","unstructured":"Deitcher SR, Carman TL, Kottke-Marchant K: Simultaneous deep venous thrombosis and acquired factor VIII inhibitor. Clin App Thromb Hemost 2002, 8:375\u2013379.","journal-title":"Clin App Thromb Hemost"},{"key":"13_CR46","first-page":"366","volume":"13","author":"S.S. Pierangeli","year":"2006","unstructured":"Pierangeli SS, Chen PP, Gonzalez EB: Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Op Hematol 2006, 13:366\u2013375.","journal-title":"Curr Op Hematol"},{"key":"13_CR47","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","volume":"126","author":"J. Ansell","year":"2004","unstructured":"Ansell J, Hirsh J, Poller L, et al.: The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:204S\u2013233S.","journal-title":"Chest"},{"key":"13_CR48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1592\/phco.24.9.838.36102","volume":"24","author":"T.K. Rosborough","year":"2004","unstructured":"Rosborough TK, Shepherd MF: Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy 2004, 24:838\u2013842.","journal-title":"Pharmacotherapy"},{"key":"13_CR49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","volume":"348","author":"P.M. Ridker","year":"2003","unstructured":"Ridker PM, Goldhaber SZ, Danielson E, et al.: Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003, 348:1425\u20131434.","journal-title":"N Engl J Med"},{"key":"13_CR50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","volume":"3","author":"G. Finazzi","year":"2005","unstructured":"Finazzi G, Marchioli R, Brancaccio V, et al.: A randomized clinical trial of high-intensity Warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005, 3:848\u2013853.","journal-title":"J Thromb Haemost"},{"key":"13_CR51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001721-200406000-00011","volume":"15","author":"J. Thom","year":"2004","unstructured":"Thom J, Ivey L, Gilmore G, Eikelboom JW: Evaluation of the phospholipid-rich dilute Russell\u2019s viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant. Blood Coagul Fibrinolysis 2004, 15:353\u2013357.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","volume":"126","author":"S.M. Bates","year":"2004","unstructured":"Bates SM, Greer IA, Hirsh J, Ginsberg JS: Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:627S\u2013644S.","journal-title":"Chest"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-008-0013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0013-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:49:48Z","timestamp":1559422188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-008-0013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11926-008-0013-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}